FLSM
AURA icon

Frazier Life Sciences Management’s Aura Biosciences AURA Stock Holding History

Frazier Life Sciences Management’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$50.4M Buy
7,100,000
+2,000,000
+39% +$14.3M 1.1% 18
2026
Q1 		$34.1M Hold
5,100,000
– – 0.88% 23
2025
Q4 		$27.8M Hold
5,100,000
– – 0.75% 28
2025
Q3 		$31.5M Hold
5,100,000
– – 0.94% 23
2025
Q2 		$31.9M Buy
+5,100,000
New +$29.8M 1.28% 18

Other funds holding AURA

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return

Frazier Life Sciences Management's AURA Position: Q2 2026 in Review

Frazier Life Sciences Management increased its Aura Biosciences (AURA) stake by 39% in Q2 2026, buying an estimated $14.3M and bringing the position to 7,100,000 shares worth $50.4M. The position accounts for 1.1% of the portfolio, ranked #18.

Frazier Life Sciences Management first reported a position in AURA in Q2 2025 and has held it in 5 quarters since. 146 funds tracked by Wall St. Rank hold AURA as of Q2 2026.

  • Frazier Life Sciences Management held 7,100,000 shares of Aura Biosciences worth $50.4M as of Q2 2026.
  • Frazier Life Sciences Management bought 2,000,000 Aura Biosciences shares in Q2 2026, an estimated $14.3M.
  • Aura Biosciences made up 1.1% of Frazier Life Sciences Management's portfolio in Q2 2026, its #18 holding.
  • Frazier Life Sciences Management first reported a position in Aura Biosciences in Q2 2025 and has held it in 5 quarters since.
  • 146 funds tracked by Wall St. Rank held Aura Biosciences as of Q2 2026.

Based on Frazier Life Sciences Management's 13F filing for Q2 2026, filed 14 Aug 2026.